Animal models for the development of cancer immunotherapy. (2022)

• Record Type: Book
• Further Information: Note: Edited by Seng-Lai Tan.
• Editors: Tan, Seng-Lai
• Contents: Table of Content Introduction Kannan Karupiah, Mithun Khattar 1. Transplantable Syngeneic Tumor Models Richard Woessner, Simon Dovedi, Robert Wilkinson 2. Genetically Engineered Mouse Models (GEMM) in Cancer Immunotherapy R&D Zhao Chen 3. Mouse Tumor Homografts Recapitulate Human Molecular Pathogenesis Rajendra Kumari, Davy Ouyang, Henry Li. 4. Modeling Resistance to Immune Checkpoint Blockade Michael Quigley, Matthew J. Meyer and Kanstantsin Katlinski 5. Orthotopic Mouse Models of Colorectal Cancer and Imaging Techniques Ce Yuan, Xianda Zhao, Dechen Wangmo, Duha Alshareef, Subbaya Subramanian 6. Preclinical Osteoimmuno-oncology Models to Study Effects of Immunotherapies on Bone Metastasis Tiina E. Kähkönen, Jussi M. Halleen, Jenni Bernoulli 7. Humanized mouse models for cancer immunotherapy: a focus on human PBMC and HSPC reconstitution Zhuo Li, Xiao Yang, Xiaomin Song 8. Bone Marrow-Liver-Thymus (BLT) Humanized Mice as a Tool to Assess Checkpoint Inhibitor Adverse Events Kenrick M. Semple, Alan D. Knapton and Kristina E. Howard 9. Development of Swine Models for Cancer Research: SCID Pigs and Other Emerging Pig Models Adeline N Boettcher and Christopher K Tuggle Index
• Edition: 1st
• Publisher Details: Hoboken : John Wiley & Sons, Inc
• Publication Date: 2022
• Extent: 1 online resource
• Subjects: 616.994061; Cancer -- Immunotherapy; Cancer -- Animal models
• Languages: English
• ISBNs: 9781119535317
• Related ISBNs: 9781119535287
• Notes: Note: Description based on CIP data; resource not viewed.
• Access Rights: Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
• Access Usage: Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.